SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.

Autor: Theard, Patricia L., Linke, Amanda J., Sealover, Nancy E., Daley, Brianna R., Yang, Johnny, Cox, Katherine, Kortum, Robert L.
Zdroj: Molecular Oncology; Mar2024, Vol. 18 Issue 3, p641-661, 21p
Databáze: Complementary Index
Externí odkaz: